HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chun-Wen Cheng Selected Research

Estrogens (Estrogen)

1/2011Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development.
3/2010Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk.
9/2008Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan.
1/2005Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chun-Wen Cheng Research Topics

Disease

25Neoplasms (Cancer)
05/2021 - 01/2005
15Breast Neoplasms (Breast Cancer)
05/2021 - 01/2005
7Neoplasm Metastasis (Metastasis)
02/2021 - 09/2007
5Carcinogenesis
01/2018 - 09/2007
4Lymphatic Metastasis
01/2014 - 02/2010
4Parkinson Disease (Parkinson's Disease)
01/2011 - 06/2005
3Infections
06/2022 - 11/2013
3Bacteremia
12/2018 - 08/2015
3Prostatic Neoplasms (Prostate Cancer)
10/2017 - 09/2013
2Ductal Carcinoma
05/2021 - 12/2012
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2018 - 05/2016
2Inflammation (Inflammations)
11/2017 - 01/2016
1Communicable Diseases (Infectious Diseases)
06/2022
1COVID-19
12/2021
1Fungemia
11/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
12/2020
1Fibrosis (Cirrhosis)
09/2020
1Mouth Neoplasms (Oral Cancer)
09/2020
1Chronic Renal Insufficiency
09/2020
1Tooth Fractures
01/2019
1Peptic Ulcer (Peptic Ulcers)
01/2019
1Pain (Aches)
11/2017
1Death (Near-Death Experience)
10/2017
1Mitochondrial Diseases (Mitochondrial Disease)
10/2017
1Glioma (Gliomas)
01/2016
1Drug-Related Side Effects and Adverse Reactions
01/2016
1Hepatitis
01/2016
1Tuberculosis (Tuberculoses)
01/2016
1Lung Neoplasms (Lung Cancer)
12/2015
1Pneumonia (Pneumonitis)
06/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2013

Drug/Important Bio-Agent (IBA)

5MicroRNAs (MicroRNA)IBA
05/2021 - 08/2012
4Proteins (Proteins, Gene)FDA Link
01/2018 - 09/2013
4Matrix Metalloproteinases (MMPs)IBA
01/2018 - 02/2010
4Estrogens (Estrogen)FDA Link
01/2011 - 01/2005
3CateninsIBA
02/2021 - 08/2012
3Anti-Bacterial Agents (Antibiotics)IBA
03/2020 - 11/2013
3CaspasesIBA
01/2018 - 12/2013
3Cyclin D1IBA
02/2017 - 08/2012
3Messenger RNA (mRNA)IBA
09/2013 - 09/2007
2VancomycinFDA LinkGeneric
06/2022 - 12/2018
2Carbapenems (Carbapenem Antibiotics)IBA
06/2022 - 06/2015
2VimentinIBA
02/2021 - 08/2012
2Biomarkers (Surrogate Marker)IBA
12/2020 - 08/2012
2Pharmaceutical PreparationsIBA
03/2020 - 11/2017
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2011 - 09/2008
2DNA (Deoxyribonucleic Acid)IBA
03/2010 - 01/2005
1Anti-Infective Agents (Microbicides)IBA
06/2022
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2021
1Chemokine ReceptorsIBA
05/2021
1Particulate MatterIBA
02/2021
1Cadherins (E-Cadherin)IBA
02/2021
1CathepsinsIBA
02/2021
1AdiponectinIBA
12/2020
1CarcinogensIBA
09/2020
1Arecoline (Arecolin)IBA
09/2020
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2020
1Checkpoint Kinase 1IBA
12/2019
1Apoptosis Regulatory ProteinsIBA
12/2019
1DiosgeninIBA
12/2019
1Third Generation CephalosporinsIBA
01/2019
1Linezolid (Zyvox)FDA Link
12/2018
1DaptomycinFDA Link
12/2018
1SuspensionsIBA
01/2018
1SaponinsIBA
01/2018
1protodioscinIBA
01/2018
1Indomethacin (Indometacin)FDA LinkGeneric
11/2017
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2017
1omega-Chloroacetophenone (Mace)IBA
10/2017
1norcantharidinIBA
10/2017
1Cantharidin (Cantharides)IBA
10/2017
1FlavonoidsIBA
05/2016
1Sorafenib (BAY 43-9006)FDA Link
05/2016
1Antineoplastic Agents (Antineoplastics)IBA
05/2016
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
05/2016
1Caspase 8 (Caspase-8)IBA
05/2016
1fisetinIBA
05/2016
1Caspase 3 (Caspase-3)IBA
05/2016
1Tight Junction ProteinsIBA
03/2016
1ClaudinsIBA
03/2016
1Rifampin (Rifampicin)FDA LinkGeneric
01/2016
1Isoniazid (Ftivazide)FDA LinkGeneric
01/2016
1Biological ProductsIBA
01/2016
1PTX3 proteinIBA
01/2016
1PyrazinamideFDA LinkGeneric
01/2016
1Transcription Factors (Transcription Factor)IBA
12/2015
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2015
1CoagulaseIBA
08/2015
1SulbactamFDA LinkGeneric
06/2015
1sultamicillin (ampicillin-sulbactam)FDA LinkGeneric
06/2015
1PAR-1 ReceptorIBA
01/2014
1Estrogen ReceptorsIBA
01/2014

Therapy/Procedure

5Therapeutics
06/2022 - 02/2011
2Lasers (Laser)
11/2021 - 01/2018
2Duration of Therapy
12/2018 - 06/2015
1Length of Stay
06/2022
1Heterologous Transplantation (Xenotransplantation)
05/2021
1Inlays (Inlay)
01/2019
1Drug Therapy (Chemotherapy)
05/2016
1Catheters
01/2016